Finance

Lists
4892:TYO
Cyfuse Biomedical KK
Â¥648.00
-1.07%
(-7.00) 1D
Oct 5, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4892...
Open
Â¥651
High
Â¥655
Low
Â¥641
Mkt. cap
6.54B
Avg. vol.
63.26K
Volume
47.60K
52-wk high
Â¥764
52-wk low
Â¥487
EPS
-Â¥82
No. of employees
23
Open
Â¥651
High
Â¥655
Low
Â¥641
Mkt. cap
6.54B
Avg. vol.
63.26K
Volume
47.60K
52-wk high
Â¥764
52-wk low
Â¥487
EPS
-Â¥82
No. of employees
23
News stories
From web sources and news partners
About Cyfuse Biomedical KK
CEO-
Employees23
FoundedAug 11, 2010
Headquarters-
SectorHealth care
Websitecyfusebio.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
32.00M
169.00M
28.00M
76.00M
Cost of goods sold
21.00M
81.00M
8.00M
31.00M
Cost of revenue
21.00M
81.00M
8.00M
31.00M
Research and development expenses
-
416.00M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
230.00M
-203.00M
236.00M
246.00M
Operating expense
230.00M
227.00M
236.00M
246.00M
Total operating expenses
251.00M
308.00M
244.00M
277.00M
Operating income
-219.00M
-139.00M
-216.00M
-201.00M
Other non operating income
-14.00M
20.00M
-3.00M
-5.00M
EBT including unusual items
-235.00M
-125.00M
-224.00M
-209.00M
EBT excluding unusual items
-235.00M
-125.00M
-224.00M
-209.00M
Income tax expense
-
1.00M
-
1.00M
Effective tax rate
-
-0.80%
-
-0.48%
Other operating expenses
-
-
-
-
Net income
-235.00M
-126.00M
-224.00M
-210.00M
Net profit margin
-734.38%
-74.56%
-800.00%
-276.32%
Earnings per share
-
-
-
-
Interest and investment income
2.00M
-
1.00M
2.00M
Interest expense
-4.00M
-6.00M
-6.00M
-5.00M
Net interest expenses
-2.00M
-6.00M
-5.00M
-3.00M
Depreciation and amortization charges
-
14.00M
-
-
EBITDA
-209.50M
-129.75M
-206.75M
-194.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps